中文 | English
Return
Total: 16 , 1/2
Show Home Prev Next End page: GO
MeSH:(Human papillomavirus 16/*immunology)

1.Distribution of serum antibodies against human papillomavirus 16 and 18 among high-risk women to cervical cancer.

Mandong FEI ; Jiayuan LI ; Jingchang DU ; Jia YOU ; Shaokai ZHANG ; Wei HE ; Leni KANG ; Fanghui ZHAO ; Youlin QIAO ; Yuzhi SI ; Xiaoping FAN ; Wen CHEN

Chinese Journal of Epidemiology 2014;35(5):514-518

2.Detection of neutralizing antibodies and DNA of human papillomavirus 16, 18 in women aged 18-45 years in Funing, Jiangsu province.

Wenyu LIU ; Feixue WEI ; Jie TANG ; Shangbo YANG ; Yachun GAO ; Ting WANG ; Yunfei JIANG ; Mei LI ; Ying HONG ; Kai CHU ; Wen CHEN ; Yuemei HU ; Fengcai ZHU

Chinese Journal of Epidemiology 2016;37(3):406-409

3.Establishment and application of human papillomavirus type 16 pseudovirions neutralization assay.

Wu-Xun LU ; Tong CHENG ; Shao-Wei LI ; Hui-Rong PAN ; Wen-Tong SHEN ; Yi-Xin CHEN ; Tao ZHANG ; Zhou ZHENG ; Jun ZHANG ; Ning-Shao XIA

Chinese Journal of Biotechnology 2006;22(6):990-995

4.Production of human papillomavirus type 16 virus-like particles and its immunogenicity.

Min-Xi WEI ; Shao-Wei LI ; Bo HUANG ; Wen-Tong SHEN ; Yong-Zai SU ; Chun-Hua ZHANG ; Ying GU ; Hai-Lian DU ; Jun ZHANG ; Ning-Shao XIA

Chinese Journal of Virology 2009;25(4):245-250

5.Expression purification and clinical application of high-risk HPV16 E4 gene.

Yan-e GAO ; Hui HUI ; Ju ZHANG ; Jiang-bo FAN ; Xiao-jun YAN

Journal of Central South University(Medical Sciences) 2008;33(8):676-681

6.The effect of HPV16E7 DNA vaccine transdermal delivery with microneedle array.

Hui GAO ; Jin-Chun PAN ; Bing CHEN ; Zheng-Feng XUE ; Hou-Da LI

Chinese Journal of Preventive Medicine 2008;42(9):663-666

7.Safety and immunogenicity of human papillomavirus-16/18 AS04-adjuvanted vaccine in healthy Chinese females aged 15 to 45 years: a phase I trial.

Feng-Cai ZHU ; Chang-Gui LI ; Hong-Xing PAN ; Yi-Ju ZHANG ; Dan BI ; Hai-Wen TANG ; Sanjoy DATTA

Chinese Journal of Cancer 2011;30(8):559-564

8.Identificaiton of Novel Immunogenic Human Papillomavirus Type 16 E7-Specific Epitopes Restricted to HLA-A*33;03 for Cervical Cancer Immunotherapy.

Sunghoon KIM ; Hye Won CHUNG ; Hoon Young KONG ; Jong Baeck LIM

Yonsei Medical Journal 2017;58(1):43-50

9.Linkage of modified human papillomavirus type 16 E7 to CD40 ligand enhances specific CD8+ T-lymphocyte induction and anti-tumour activity of DNA vaccine.

Qing-yong WANG ; Yu-fei XU ; Dong-sheng FAN ; Qing-lin PENG ; Ting ZHANG ; Xue-mei XU

Acta Academiae Medicinae Sinicae 2007;29(5):584-591

10.Construction and immunological evaluation of recombinant adenovirus containing codon-modified HPV 16 L1 gene.

Yu-bai ZHOU ; Ling ZHOU ; Ze-lin LI ; Wang SHENG ; Yi ZENG

Chinese Journal of Experimental and Clinical Virology 2008;22(1):18-20

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 16 , 1/2 Show Home Prev Next End page: GO